Davis Polk & Wardwell and Jia Yuan Law Offices have advised Chinese clinical trial and research firm Hangzhou Tigermed Consulting on its $1.38 billion Hong Kong IPO, with Freshfields Bruckhaus Deringer and Zhong Lun Law Firm representing the sponsors.
Tian Yuan Law firm and Commerce & Finance Law Offices have led on two new health sector initial public offerings of Hygeia Healthcare and Hepalink Pharma in Hong Kong. They’ve advised the issuers and joint sponsors respectively in both deals.
Paul Hastings and Commerce & Finance Law Offices have advised China Bohai Bank on its $1.78 billion initial public offering in Hong Kong, with Clifford Chance and Haiwen & Partners advising the joint sponsors.
DeHeng Law Offices and Simpson Thacher & Bartlett have advised China vaping device manufacturer Smoore on its $885 million initial public offering in Hong Kong, with Reed Smith Richards Butler, Reed Smith and Zhong Lun Law Firm advising the sole sponsor Citic Securities.
AZB & Partners and Davis Polk & Wardwell have advised Jio Platforms on its $4.5 billion sale of a 7.73 percent stake to Google, which was represented by Freshfields Bruckhaus Deringer and J. Sagar Associates.
Nishimura & Asahi has advised Japanese insurance company Sompo Holdings on its $500 million investment in Silicon Valley data analytics company Palantir Technologies.
Skadden, Arps, Slate, Meagher & Flom and Han Kun Law Offices have advised Chinese car comparison website Bitauto and classifieds portal 58.com, both previously listed in New York, in going private with the transactions being valued at $1.1 billion and $8.7 billion, respectively.
Linklaters is advising Cathay Pacific Airways on its HK$39 billion ($5 billion) Hong Kong government-backed recapitalisation plan, aimed at shoring up the city’s flag-carrier at a time when airlines globally have been hit by a travel slump triggered by the coronavirus pandemic.
Skadden, Arps, Slate, Meagher & Flom, Gibson, Dunn & Crutcher and Zhong Lun Law Firm have advised China internet heavyweight NetEase on its $2.7 billion secondary listing in Hong Kong, with Davis Polk & Wardwell and JunHe advising the joint underwriters.